Presentation TCT 2025 TCT 196: Application of ILUMIEN IV Trial Criteria in In-stent Restenosis Cohort Presenter: Yat Him Marcus Chan October 28, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 TCT 199: Use of the Esprit BTK Biodegradable Stent Scaffold for Recurrent Coronary In-stent Restenosis Presenter: Bilal M. Murad October 28, 2025 More slides + Presentation TCT 2025 TCT 17: Comprehensive Phenotypic and Institutional Variation in Contemporary TAVR Recipients: Insights from a Regional Multicenter Cohort Presenter: Ming Zhang October 28, 2025 Presentation TCT 2025 TCT 19: Long-Term Clinical Outcomes Following Transcatheter Aortic Valve Replacement (TAVR): A Decade of Data Presenter: Judah Rajendran October 28, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 TCT 199: Use of the Esprit BTK Biodegradable Stent Scaffold for Recurrent Coronary In-stent Restenosis Presenter: Bilal M. Murad October 28, 2025
Presentation TCT 2025 TCT 17: Comprehensive Phenotypic and Institutional Variation in Contemporary TAVR Recipients: Insights from a Regional Multicenter Cohort Presenter: Ming Zhang October 28, 2025
Presentation TCT 2025 TCT 19: Long-Term Clinical Outcomes Following Transcatheter Aortic Valve Replacement (TAVR): A Decade of Data Presenter: Judah Rajendran October 28, 2025